文献速递肝胆胰外科围术期管理与 ERAS

肝脏手术加速康复路径减少术后门诊阿片类药物使用

Enhanced recovery in liver surgery decreases postoperative outpatient use of opioids.
PubMed 文献 · Surgery · 2019-05-15

该研究对比2011-2018年244例肝切除患者中加速康复路径(147例)与传统路径(97例)的差异,发现加速康复患者出院时传统阿片类药物处方率(26% vs 79%,P<.001)及首次术后随访阿片类药物需求率(19% vs 61%,P<.001)均显著更低,而疼痛评分相似(中位2/10,P=.500)。多变量分析显示传统路径是首次随访时传统阿片类药物使用的独立预测因素(OR 6.4,95%CI 3.5-12.1;P<.001)。

要点

  • 肝脏手术加速康复路径可显著降低出院阿片类药物处方率及门诊阿片类药物使用。
  • 加速康复路径在减少阿片类使用的同时,患者报告的疼痛评分与传统路径相当。
  • 传统康复路径是术后首次随访时阿片类药物使用的独立危险因素。

核心结论

  • 实施包含阿片类药物节约技术的肝脏手术加速康复路径,与肿瘤肝脏手术后出院阿片类药物处方减少及门诊阿片类药物使用减少相关,同时达到相同的疼痛控制水平。

研究设计与样本

  • 回顾性队列研究,纳入2011-2018年连续接受肝切除的患者244例,其中加速康复路径147例,传统路径97例。

主要发现

  • 加速康复患者年龄更大(中位57岁 vs 52岁,P=.031),微创手术比例更高(37% vs 16%,P<.001),主要并发症更少(2% vs 9%,P=.011)。
  • 加速康复患者出院时传统阿片类药物处方率更低(26% vs 79%,P<.001),首次术后随访需要阿片类药物的比例更低(19% vs 61%,P<.001)。
  • 两组患者报告的疼痛评分相似(中位2/10,P=.500)。
  • 多变量分析显示,传统康复路径与首次随访时传统阿片类药物使用独立相关(OR 6.4,95%CI 3.5-12.1;P<.001)。

关键数值与推荐

  • 肝脏手术加速康复方案包括阿片类药物节约镇痛、目标导向液体治疗、术后早期进食和早期下床活动。

临床怎么用

  • 对于接受肿瘤肝脏手术的患者,可实施包含阿片类药物节约技术的加速康复路径,以减少出院阿片类药物处方和门诊阿片类药物使用,同时维持疼痛控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pathways of enhanced recovery in liver surgery decrease inpatient opioid use; however, little data exist regarding their effect on discharge prescriptions and post-discharge opioid intake. METHODS: For consecutive patients undergoing liver resection from 2011-2018, clinicopathologic factors were compared between patients exposed to enhanced recovery vs. traditional care pathways. Multivariable analysis was used to determine factors predictive for traditional opioid use at the first postoperative follow-up. The enhanced recovery in liver surgery protocol included opioid-sparing analgesia, goal-directed fluid therapy, early postoperative feeding, and early ambulation. RESULTS: Of 244 cases, 147 enhanced recovery patients were compared with 97 traditional pathway patients. Enhanced recovery patients were older (median 57 years vs 52 years, P = .031) and more frequently had minimally invasive operations (37% vs 16%, P < .001), with fewer major complications (2% vs 9%, P = .011). Enhanced recovery patients were less likely to be discharged with a prescription for traditional opioids (26% vs 79%, P < .001) and less likely to require opioids at their first postoperative visit (19% vs 61%, P < .001) despite similarly low patient-reported pain scores (median 2/10 both groups, P = .500). On multivariable analysis, the traditional recovery pathway was independently associated with traditional opioid use at the first follow-up (odds ratio 6.4, 95% confidence interval 3.5-12.1; P < .001). CONCLUSION: The implementation of an enhanced recovery in liver surgery pathway with opioid-sparing techniques was associated with decreased postoperative discharge prescriptions for opioids and outpatient opioid use after oncologic liver surgery, while achieving the same level of pain control. For this and other populations at risk of persistent opioid use, enhanced recovery strategies can eliminate excess availability of opioids.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Lillemoe HA, Marcus RK, Day RW, et al. Enhanced recovery in liver surgery decreases postoperative outpatient use of opioids. Surgery. 2019. PMID: 31103198. doi:10.1016/j.surg.2019.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。